Polypeptide vaccine
AssigneeAgency for Science, Technology and Research
InventorQi Zeng
Life of this patent
Estimating the term…
Abstract
We provide a polypeptide vaccine for treatment and prevention of cancer, particularly prevention of metastasis of cancer. Also provided are methods of treating or preventing cancer, and pharmaceutical compositions comprising the polypeptide vaccine.
Claims27
A method for the treatment or prevention of cancer, the method comprising administering to a patient in need thereof a therapeutically or prophylactically effective amount of a polypeptide which comprises a 10 to 150 amino acid fragment of an intracellular oncoprotein.
A method for preventing cancer metastasis in a patient with cancer, the method comprising:
- a) identifying an intracellular oncoprotein specific to the patient's cancer;
- and
- b) administering a fragment of between 10 and 150 amino acids of that intracellular oncoprotein to the patient.
A method for treating or preventing cancer in a person, the method comprising:
- a) determining whether a person is suffering from, or likely to develop, a cancer associated with an intracellular oncoprotein;
- and
- b) administering to that person a fragment of that intracellular oncoprotein or peptide based on a fragment of that intracellular oncoprotein, the fragment or peptide being between 10 and 150 amino acids in length.
A pharmaceutical composition comprising an intracellular oncoprotein fragment, or a variant, homologue or derivative thereof, together with a pharmaceutically acceptable excipient, diluent or carrier.
Dependencies are inferred from the claim text.